Task Shifting for Initiation and Monitoring of Antiretroviral Therapy for HIV-Infected Adults in Uganda: The SHARE Trial.

BACKGROUND: With countries moving toward the World Health Organization's "Treat All" recommendation, there is a need to initiate more HIV-infected persons into antiretroviral therapy (ART). In resource-limited settings, task shifting is 1 approach that can address clinician shortages. SETTING: Uganda. METHODS: We conducted a randomized controlled trial to test if nurse-initiated and monitored ART (NIMART) is noninferior to clinician-initiated and monitored ART in HIV-infected adults in Uganda. Study participants were HIV-infected, ART-naive, and clinically stable adults. The primary outcome was a composite end point of any of the following: all-cause mortality, virological failure, toxicity, and loss to follow-up at 12 months post-ART initiation. RESULTS: Over half of the study cohort (1,760) was women (54.9%). The mean age was 35.1 years (SD 9.51). Five hundred thirty-three (31.6%) participants experienced the composite end point. At 12 months post-ART initiation, nurse-initiated and monitored ART was noninferior to clinician-initiated and monitored ART. The intention-to-treat site-adjusted risk differences for the composite end point were -4.1 [97.5% confidence interval (CI): = -9.8 to 0.2] with complete case analysis and -3.4 (97.5% CI: = -9.1 to 2.5) with multiple imputation analysis. Per-protocol site-adjusted risk differences were -3.6 (97.5% CI: = -10.5 to 0.6) for complete case analysis and -3.1 (-8.8 to 2.8) for multiple imputation analysis. This difference was within hypothesized margins (6%) for noninferiority. CONCLUSIONS: Nurses were noninferior to clinicians for initiation and monitoring of ART. Task shifting to trained nurses is a viable means to increase access to ART. Future studies should evaluate NIMART for other groups (e.g., children, adolescents, and unstable patients).

Implementation and evaluation of a Project ECHO telementoring program for the Namibian HIV workforce.

BACKGROUND: The Namibian Ministry of Health and Social Services (MoHSS) piloted the first HIV Project ECHO (Extension for Community Health Outcomes) in Africa at 10 clinical sites between 2015 and 2016. Goals of Project ECHO implementation included strengthening clinical capacity, improving professional satisfaction, and reducing isolation while addressing HIV service challenges during decentralization of antiretroviral therapy. METHODS: MoHSS conducted a mixed-methods evaluation to assess the pilot. Methods included pre/post program assessments of healthcare worker knowledge, self-efficacy, and professional satisfaction; assessment of continuing professional development (CPD) credit acquisition; and focus group discussions and in-depth interviews. Analysis compared the differences between pre/post scores descriptively. Qualitative transcripts were analyzed to extract themes and representative quotes. RESULTS: Knowledge of clinical HIV improved 17.8% overall (95% confidence interval 12.2-23.5%) and 22.3% (95% confidence interval 13.2-31.5%) for nurses. Professional satisfaction increased 30 percentage points. Most participants experienced reduced professional isolation (66%) and improved CPD credit access (57%). Qualitative findings reinforced quantitative results. Following the pilot, the Namibia MoHSS Project ECHO expanded to over 40 clinical sites by May 2019 serving more than 140 000 people living with HIV. CONCLUSIONS: Similar to other Project ECHO evaluation results in the United States of America, Namibia's Project ECHO led to the development of ongoing virtual communities of practice. The evaluation demonstrated the ability of the Namibia HIV Project ECHO to improve healthcare worker knowledge and satisfaction and decrease professional isolation.

Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.

PURPOSE: Troglitazone, the first drug of the thiazolidinediones class for type II diabetes, was first marketed in March 1997 and was removed from the U.S. market 36 months later after 90 cases of liver failure were reported despite multiple warnings containing liver enzyme monitoring recommendations. Rosiglitazone has been available since June 1999 and is still on the market. The purpose of this study was to evaluate the impact of labeled hepatic enzyme monitoring for troglitazone and rosiglitazone. METHODS: Drug cohorts were assembled, using population-based fee-for-service Medicaid claims, for patients between 18 and 65 years of age who had received at least one troglitazone (n = 7226) or rosiglitazone (n = 1480) prescription between 1 April, 1997, and 21 March, 2000. The outcome of interest was the percentage of patients, based on their first treatment episode, who had baseline and post-baseline liver enzyme testing. RESULTS: Overall baseline testing was under 9% before regulatory actions, increased to 14% after the first two 'Dear Doctor' letters issued by the FDA in October and December 1997, and peaked to about 26% afterwards. Coincident with the marketing of rosiglitazone and the fourth 'Dear Doctor' letter issued in June 1999, baseline testing dropped to 18%. Baseline testing increased 2.5-fold (race-sex-age adjusted) after regulatory action. Achieving 50% post-baseline testing took approximately 6 months for both drugs. CONCLUSION: Regulatory actions had only modest effects on the incidence of liver monitoring. More effective and timely communication strategies, health provider prescribing interventions and modification of health provider behaviors to enhance compliance with recommended risk management measures need to be identified, evaluated and implemented.

El predominio heterosexual del SIDA en la República Dominicana / AIDS heterosexual predominance in the Dominican Republic

Se exponen los datos de evolución del SIDA en la República Dominicana durante el período comprendido entre 1983 y 1989. La definición del SIDA se basó en una prueba serológica positiva para el virus de la inmunodeficiencia humana (VIH) y los criterios clínicos estándares. Se notificaron al Ministerio de Salud 1 202 casos de SIDA (820 varones, 372 mujeres y 10 de sexo no verificado), con una tasa global de 17 casos por 100 000 personas. Se apreció una evolución rápida de la epidemia, habiéndose notificado 43 por ciento del total de casos en 1989. La exposición heterosexual dio cuenta de 53 por ciento (593) de los casos, con una razón varones/mujeres de 2,2:1, lo cual sugiere un país con patrón I/II según los criterios de la OMS. La prevalencia fue máxima en las zonas turísticas urbanas de Santo Domingo y Puerto Plata y sus alrededores y en los distritos de alta concentración de barracas de plantaciones de azúcar, en donde trabajan y viven trabajadores de Haití y de la República Dominicana. Se describe la distribución de casos de SIDA según las categorías de transmisión-exposición, edad, sexo, año del diagnóstico y distrito. El Programa Nacional de Vigilancia del SIDA podría mejorarse si se validaran las categorías de exposición-transmisión investigando determinados casos y se mejorara la notificación mediante la capacitación del personal de salud asistencial. Los datos de vigilancia epidemiológica contribuirán a que las actividades de salud pública futuras se dirijan a las regiones y personas expuestas a mayor riesgo

El predominio heterosexual del SIDA en la República Dominicana / AIDS heterosexual predominance in the Dominican Republic

Se exponen los datos de evolución del SIDA en la República Dominicana durante el período comprendido entre 1983 y 1989. La definición del SIDA se basó en una prueba serológica positiva para el virus de la inmunodeficiencia humana (VIH) y los criterios clínicos estándares. Se notificaron al Ministerio de Salud 1 202 casos de SIDA (820 varones, 372 mujeres y 10 de sexo no verificado), con una tasa global de 17 casos por 100 000 personas. Se apreció una evolución rápida de la epidemia, habiéndose notificado 43 por ciento del total de casos en 1989. La exposición heterosexual dio cuenta de 53 por ciento (593) de los casos, con una razón varones/mujeres de 2,2:1, lo cual sugiere un país con patrón I/II según los criterios de la OMS. La prevalencia fue máxima en las zonas turísticas urbanas de Santo Domingo y Puerto Plata y sus alrededores y en los distritos de alta concentración de barracas de plantaciones de azúcar, en donde trabajan y viven trabajadores de Haití y de la República Dominicana. Se describe la distribución de casos de SIDA según las categorías de transmisión-exposición, edad, sexo, año del diagnóstico y distrito. El Programa Nacional de Vigilancia del SIDA podría mejorarse si se validaran las categorías de exposición-transmisión investigando determinados casos y se mejorara la notificación mediante la capacitación del personal de salud asistencial. Los datos de vigilancia epidemiológica contribuirán a que las actividades de salud pública futuras se dirijan a las regiones y personas expuestas a mayor riesgo

El predominio heterosexual del SIDA en la Republica Dominicana

Se exponen los datos de evolucion del SIDA en la Republica Dominicana durante el periodo comprendido entre 1983 y 1989. La definicion del SIDA se baso en una prueba serologica positiva para el virus de la inmunodeficiencia humana (VIH) y los criterios clinicos estandares. Se notificaron al Ministerio de Salud 1202 casos de SIDA (820 varones, 372 mujeres y 10 de sexo no verificado), con una tasa global de 17 casos por 100.000 personas. Se aprecio una evolucion rapida de la epidemia, habiendose notificado 43 por ciento del total de casos en 1989. Se describe la destribuicion de casos de SIDA segun las categorias de transmision - exposicion, edad, sexo, ano del diagnostico y distrito.(AU)